专题：Chronic Lymphocytic Leukemia Research

This cluster of papers focuses on the genomic aberrations, treatment strategies, and prognostic factors associated with chronic lymphocytic leukemia (CLL). It covers topics such as the use of BTK inhibitors (e.g., Ibrutinib), the role of rituximab, TP53 mutations, and the impact of immunoglobulin mutations. Additionally, it explores therapeutic targets and outcomes in patients with Waldenström macroglobulinemia.
最新文献
Linperlisib causing high blood sugar and hyponatremia, leading to facial nerve paralysis and muscle nerve damage: A rare case report

article Full Text OpenAlex

ABS0416 PERSISTENT-RELAPSING SARS-CoV-2 INFECTION FOLLOWING RITUXIMAB TREATMENT FOR AUTOIMMUNE RHEUMATIC DISEASES: NATURAL HISTORY AND IMPLICATIONS FOR MANAGEMENT

article Full Text OpenAlex

Response to Letter to the Editor from Raschi et al.: “Endocrine adverse reactions of tyrosine kinase inhibitors in combination with immune checkpoint inhibitors”

article Full Text OpenAlex

Beyond BCL2 (B cell lymphoma) and BTK (Bruton tyrosine kinase) inhibitors: novel agents and resistance mechanisms for chronic lymphocytic leukemia

review Full Text OpenAlex

Comparison of Third-Generation Tyrosine Kinase Inhibitor (TKI) Ponatinib with First- and Second-Generation TKIs for Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia: A Systematic Review and Bias-Corrected Meta-analysis

review Full Text OpenAlex

Imatinib Desensitization After a Type IV Hypersensitivity Reaction in a Gastrointestinal Stromal Tumor Patient—A Case Report

article Full Text OpenAlex

SJS-TEN Spectrum Reactions to Immune Checkpoint Inhibitor Therapy and Safety of Rechallenge: A Retrospective Review

review Full Text OpenAlex

Overall Survival with Inavolisib in PIK3CA -Mutated Advanced Breast Cancer

article Full Text OpenAlex

Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial

article Full Text OpenAlex

CK2 in the spotlight: decoding its role in hematological malignancies and therapeutic applications

review Full Text OpenAlex

近5年高被引文献
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

review Full Text OpenAlex 2534 FWCI139.312

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

article Full Text OpenAlex 1790 FWCI261.463

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

article Full Text OpenAlex 1054 FWCI207.747

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

review Full Text OpenAlex 910 FWCI39.496

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

review Full Text OpenAlex 814 FWCI29.11

Diffuse Large B-Cell Lymphoma

review Full Text OpenAlex 719 FWCI30.207

KRAS mutation: from undruggable to druggable in cancer

review Full Text OpenAlex 688 FWCI18.658

Management of Rheumatoid Arthritis: An Overview

review Full Text OpenAlex 658 FWCI25.551

Trends in kinase drug discovery: targets, indications and inhibitor design

review Full Text OpenAlex 609 FWCI26.141

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

letter Full Text OpenAlex 608 FWCI0